These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-inflammatory drugs in the 21st century. Rainsford KD Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044 [TBL] [Abstract][Full Text] [Related]
3. Dual acting anti-inflammatory drugs: a reappraisal. Bertolini A; Ottani A; Sandrini M Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348 [TBL] [Abstract][Full Text] [Related]
4. Prostanoids and inflammatory pain. Chen L; Yang G; Grosser T Prostaglandins Other Lipid Mediat; 2013; 104-105():58-66. PubMed ID: 22981510 [TBL] [Abstract][Full Text] [Related]
5. COXIBs, CINODs and H₂S-releasing NSAIDs: current perspectives in the development of safer non steroidal anti-inflammatory drugs. Fiorucci S; Distrutti E Curr Med Chem; 2011; 18(23):3494-505. PubMed ID: 21756233 [TBL] [Abstract][Full Text] [Related]
6. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Bertolini A; Ottani A; Sandrini M Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982 [TBL] [Abstract][Full Text] [Related]
7. Selective cyclooxygenase inhibitors: current status. Nandakishore R; Yalavarthi PR; Kiran YR; Rajapranathi M Curr Drug Discov Technol; 2014 Jun; 11(2):127-32. PubMed ID: 24467591 [TBL] [Abstract][Full Text] [Related]
8. COX-derived prostanoid pathways in gastrointestinal cancer development and progression: novel targets for prevention and intervention. Cathcart MC; O'Byrne KJ; Reynolds JV; O'Sullivan J; Pidgeon GP Biochim Biophys Acta; 2012 Jan; 1825(1):49-63. PubMed ID: 22015819 [TBL] [Abstract][Full Text] [Related]
9. The future of traditional nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors in the treatment of inflammation and pain. Sciulli MG; Capone ML; Tacconelli S; Patrignani P Pharmacol Rep; 2005; 57 Suppl():66-85. PubMed ID: 16415488 [TBL] [Abstract][Full Text] [Related]
10. The Coxib case: Are EP receptors really guilty? Santilli F; Boccatonda A; Davì G; Cipollone F Atherosclerosis; 2016 Jun; 249():164-73. PubMed ID: 27105159 [TBL] [Abstract][Full Text] [Related]
11. New insights into COX-2 biology and inhibition. Patrignani P; Tacconelli S; Sciulli MG; Capone ML Brain Res Brain Res Rev; 2005 Apr; 48(2):352-9. PubMed ID: 15850674 [TBL] [Abstract][Full Text] [Related]
12. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases? Timmers L; Pasterkamp G; de Kleijn DP Mol Interv; 2007 Aug; 7(4):195-9, 180. PubMed ID: 17827439 [TBL] [Abstract][Full Text] [Related]
13. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review. Koeberle A; Werz O Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418 [TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract. Meyer-Kirchrath J; Schrör K Curr Med Chem; 2000 Nov; 7(11):1121-9. PubMed ID: 11032962 [TBL] [Abstract][Full Text] [Related]
20. Intracellular measurement of prostaglandin E2: effect of anti-inflammatory drugs on cyclooxygenase activity and prostanoid expression. Horton JK; Williams AS; Smith-Phillips Z; Martin RC; O'Beirne G Anal Biochem; 1999 Jun; 271(1):18-28. PubMed ID: 10361000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]